Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00331305 · ClinicalTrials.gov registry record · Phase 3
Exercise Training Versus Drug Therapy for Treating Depression in Older Adults
A Phase 3 study of Depression, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 457
- Enrollment target
- 1
- Study location
NCT00331305 is a Phase 3 study of Depression that has completed, run by Duke University. The registered enrollment target is 457 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00331305, a Phase 3 study of Depression, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 457 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of both center-based and home-based exercise versus the antidepressant drug sertraline in treating depression in middle-aged and older adults.
Conditions Studied
Interventions
- BEHAVIORAL Home-Based Exercise
- DRUG Placebo Pill
- BEHAVIORAL Supervised Exercise
- DRUG Sertraline (Zoloft)
Study Locations (1)
North Carolina
- Duke University Medical Center, Department of Psychiatry and Behavioral Sciences - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 457 participants |
| Start Date | 1999-08 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00331305
The ClinicalTrials.gov registry entry for NCT00331305 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 457 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (42% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Home-Based Exercise is the first listed.
NCT00331305 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00331305 about?
NCT00331305 is a clinical study titled "Exercise Training Versus Drug Therapy for Treating Depression in Older Adults". This study will evaluate the effectiveness of both center-based and home-based exercise versus the antidepressant drug sertraline in treating depression in middle-aged and older adults.
What is the current status of trial NCT00331305?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 457 participants. The study started on 1999-08. Estimated completion is 2007-05.
What conditions does trial NCT00331305 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00331305?
The interventions under investigation include: Home-Based Exercise (BEHAVIORAL), Placebo Pill (DRUG), Supervised Exercise (BEHAVIORAL), Sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00331305?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00331305 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.